Insulin-like growth factor- I and factors affecting it in thalassemia major.
Soliman AT, De Sanctis V, Elalaily R, Yassin M.
Indian J Endocrinol Metab. 2015 Mar-Apr;19(2):245-51. doi: 10.4103/2230-8210.131750.
PMID:25729686
Challenges in the care of individuals with severe primary insulin-like growth factor-I deficiency (SPIGFD): an international, multi-stakeholder perspective.
Backeljauw PF, Andrews M, Bang P, Dalle Molle L, Deal CL, Harvey J, Langham S, Petriczko E, Polak M, Storr HL, Dattani MT.
Orphanet J Rare Dis. 2023 Oct 7;18(1):312. doi: 10.1186/s13023-023-02928-7.
PMID:37805563
The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications.
Zemva J, Schubert M.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):322-37. doi: 10.2174/18715273113126660141.
PMID:24059318
Growth and Growth hormone - Insulin Like Growth Factor -I (GH-IGF-I) Axis in Chronic Anemias.